World's Largest Drug-Eluting Stent Registry Reaches Halfway Point In Enrollment
Fri, 01 Sep 2006 07:00 AM EST
... Boston ScientificCorporation (NYSE: BSX) announced today that enrollment has exceeded 13,000 patients in the TAXUS OLYMPIA registry, designed to evaluate the safety and performance of the Company's second-generation drug-eluting coronary stent (DES), TAXUS(R) Liberte(TM)(1), in a real-world setting. [click link for full article] ...
Related Topics
- Acupuncture point
- Trigger point
- Sirolimus
- Fluoride Rinse
- Immunization Registry
- Angioplasty
- Drug Safety
- Prescription Drugs
- Drug Side Effects
- Drug Abuse
- Drug Information
- Acupressure
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Bone Marrow
- Clozapine
- Child Abuse And Neglect
- Births, Deaths & Marriages
- Ethanol
- Trigger Point Therapy

Not Signed In -


